HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK
· Real-Time Price · USD
1.37
0.03 (2.24%)
At close: May 13, 2025, 2:44 PM
2.24% (1D)
| Bid | 1.36 |
| Market Cap | 16.69M |
| Revenue (ttm) | 43.95M |
| Net Income (ttm) | -43.5M |
| EPS (ttm) | -3.47 |
| PE Ratio (ttm) | -0.39 |
| Forward PE | -0.82 |
| Analyst | Hold |
| Ask | 1.37 |
| Volume | 38,515 |
| Avg. Volume (20D) | 81,308 |
| Open | 1.33 |
| Previous Close | 1.34 |
| Day's Range | 1.29 - 1.39 |
| 52-Week Range | 0.72 - 10.50 |
| Beta | 0.75 |
About HOOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HOOK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HOOK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
HOOKIPA Pharma Inc. is scheduled to release its earnings on May 27, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
-9.38%
HOOKIPA Pharma shares are trading lower after the ...
Unlock content with
Pro Subscription
4 months ago · proactiveinvestors.co.uk
Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPAGilead Sciences Inc (NASDAQ:GILD, ETR:GIS), the largest shareholder in HOOKIPA Pharma, has thrown its backing behind the proposed merger with Poolbeg Pharma PLC (AIM:POLB). Gilead, which holds just un...